DI GIACOMO ANNA MARIA | Professor page

Kennedy, O.J., Glassee, N., Kicinski, M., Buhrer, E., Valpione, S., Gandini, S., et al. (2025). Prognostic and predictive importance of body mass index and type 2 diabetes in the European Organisation for Research and Treatment of Cancer 1325/KEYNOTE-054 phase III trial of pembrolizumab versus placebo in resected high-risk stage III melanoma. EJC SKIN CANCER, 3 [10.1016/j.ejcskn.2025.100284]. - view more
Oldani, S., Prinzi, N., Morano, F., Cingarlini, S., Di Giacomo, A.M., Niger, M., et al. (2025). Design and rationale of the phase II PANDORA trial: first line chemo-immunotherapy in advanced Merkel cell carcinoma. FUTURE ONCOLOGY, 21(17), 2127-2133 [10.1080/14796694.2025.2514402]. - view more
Pichel, R.C., Benini, L., Romelli, M., Gandini, S., Gervaso, L., Valente, M., et al. (2025). Immune-Checkpoint Inhibitors in Lung Neuroendocrine Tumors–A Systematic Review and Meta-Analysis. ONCOTARGETS AND THERAPY, 18, 833-843 [10.2147/OTT.S515194]. - view more
Anichini, A., Caruso, F.P., Lagano, V., Noviello, T.M.R., Tufano, R., Nicolini, G., et al. (2025). Integrated multi-omics profiling reveals the role of the DNA methylation landscape in shaping biological heterogeneity and clinical behaviour of metastatic melanoma. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 44(1) [10.1186/s13046-025-03474-9]. - view more
Di Giacomo, A.M., Canetta, R., Connolly, J., Leidner, R., Zheng, W., Kim, Y., et al. (2025). Approaches to overcome the current treatment plateau in immunotherapy. EUROPEAN JOURNAL OF CANCER, 226 [10.1016/j.ejca.2025.115605]. - view more

All publications